← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Rivaroxaban currently has availability issues reported in 5 European registers: Austria, Germany, Spain, France, Italy.
Shortage ATC B01AF01 · also listed as: RIVAROXABAN · data refreshed 21 September 2026
As of 21 September 2026, 5 of the 8 tracked registers list current availability issues for Rivaroxaban, covering 12 affected product presentations. The longest-running open report was filed in Italy on 2024-12-27 and has now been open for about 21 months. Where agencies state a cause, manufacturing problems lead with 3 of the 4 stated-cause reports, followed by unexpectedly high demand with 1. The furthest expected-resolution date currently on file is 2026-10-12; the earliest is 2026-09-29. Momentum is current, not historical: 4 of the open reports were filed within the last 90 days. The issue spread across registers over time rather than at once: Italy reported first (2024-12-27), with Germany following roughly 18 months later — a pattern typical of supply problems cascading between national markets. Registers in Germany, Spain, Italy indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Rivaroxaban is coded B01AF01 — a medicine acting on blood and blood-forming organs — so clinically related products appear under “Related medicines” below.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇦🇹 Austria | Shortage Rivaroxaban +pharma 2,5 mg Filmtabletten + 4 more productsRivaroxaban 1A Pharma 2,5 mg - Filmtabletten Rivaroxaban ratiopharm 2,5 mg Filmtabletten Xarelto 10 mg Filmtabletten Xarelto 20 mg Filmtabletten | 2026-03-16 | — | — | register ↗ |
| 🇩🇪 Germany | Shortage Xarelto 1 mg/ml Granulat zur Herstellung einer Suspension zum Einnehmen | 2026-06-15 | 2026-10-02 | Sonstige Alternatives: N/A | register ↗ |
| 🇪🇸 Spain | Shortage RIVAROXABAN SANDOZ 2,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 56 comprimidos | 2026-06-10 | — | Existen otros medicamentos con el mismo principio activo y misma vía. Alternatives: Existe/n otro/s medicamento/s con el mismo principio activo y para la misma vía de administración. | register ↗ |
| 🇫🇷 France | Limited availability Xarelto 1 mg/mL, granulés pour supension buvable, flacon de 100 ml + 1 more productsXarelto 1 mg/mL, granulés pour supension buvable, flacon de 250 ml | — | 2026-07-03 | Cardiologie | register ↗ |
| 🇮🇹 Italy | Shortage RIVAROXABAN DR. REDDY'S + 3 more productsRIVAROXABAN OLPHA RIVAROXABAN ZENTIVA ITALIA XARELTO | 2024-12-27 | 2026-10-12 | Elevata richiesta: forniture discontinue (carenza relativa solo al canale ospedaliero) Alternatives: AIFA: equivalents with the same active substance are available. | register ↗ |
Every individual register entry for Rivaroxaban in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇮🇹 IT | XARELTO | Shortage | 2026-09-01 | 2026-10-12 | Elevata richiesta/problemi produttivi |
| 🇮🇹 IT | RIVAROXABAN OLPHA | Shortage | 2026-07-26 | 2026-09-29 | Problemi produttivi |
| 🇦🇹 AT | Xarelto 10 mg Filmtabletten | Limited availability | 2026-07-23 | — | |
| 🇮🇹 IT | RIVAROXABAN DR. REDDY'S | Shortage | 2026-07-15 | — | Elevata richiesta: forniture discontinue (carenza relativa s |
| 🇩🇪 DE | Xarelto 1 mg/ml Granulat zur Herstellung einer Suspension zum Einnehme | Shortage | 2026-06-15 | 2026-10-02 | Sonstige |
| 🇪🇸 ES | RIVAROXABAN SANDOZ 2,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 56 | Shortage | 2026-06-10 | — | Existen otros medicamentos con el mismo principio activo y m |
| 🇦🇹 AT | Rivaroxaban ratiopharm 2,5 mg Filmtabletten | Limited availability | 2026-05-29 | — | |
| 🇦🇹 AT | Xarelto 20 mg Filmtabletten | Limited availability | 2026-05-14 | — | |
| 🇦🇹 AT | Rivaroxaban +pharma 2,5 mg Filmtabletten | Shortage | 2026-04-21 | — | |
| 🇦🇹 AT | Rivaroxaban 1A Pharma 2,5 mg - Filmtabletten | Limited availability | 2026-03-16 | — | |
| 🇮🇹 IT | RIVAROXABAN ZENTIVA ITALIA | Shortage | 2024-12-27 | — | Problemi produttivi |
| 🇫🇷 FR | Xarelto 1 mg/mL, granulés pour supension buvable, flacon de 100 ml | Resolved | — | 2026-07-03 | Cardiologie |
| 🇫🇷 FR | Xarelto 1 mg/mL, granulés pour supension buvable, flacon de 250 ml | Limited availability | — | — | Cardiologie |
Yes. As of 21 September 2026, availability issues are reported in: Austria, Germany, Spain, France, Italy. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2026-09-29 to 2026-10-12. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
6 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency registers that list Rivaroxaban: BASG (Austria), BfArM (Germany), AEMPS CIMA (Spain), ANSM (France), AIFA (Italy). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Rivaroxaban — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/rivaroxaban/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Rivaroxaban availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/rivaroxaban/">Rivaroxaban shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>